Attention deficit/hyperactivity disorder across the lifespan

Annual Review of Medicine

Volumn 53, Issue , 2002, Pages 113-131

  Wilens, Timothy E ^a   Biederman, Joseph ^a   Spencer, Thomas J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

ADD; ADHD; Antidepressants; Comorbidity; Stimulants

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; AMPHETAMINE DERIVATIVE; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; CATAPRESS; CENTRAL STIMULANT AGENT; CLONIDINE; DEXAMPHETAMINE; GUANFACINE; IMIPRAMINE; METADATE SR; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PEMOLINE MAGNESIUM; RITADEX; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AFFECTIVE NEUROSIS; AGITATION; ANXIETY NEUROSIS; ATTENTION DEFICIT DISORDER; COMORBIDITY; CONFUSION; CONSTIPATION; DEPRESSION; GASTROINTESTINAL SYMPTOM; HUMAN; INSOMNIA; IRRITABILITY; MANIC DEPRESSIVE PSYCHOSIS; NAUSEA; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; REVIEW; SUBSTANCE ABUSE; TIC; WEIGHT REDUCTION; XEROSTOMIA;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COMORBIDITY; FEMALE; HUMANS; MALE; MENTAL DISORDERS; TREATMENT OUTCOME;

EID: 0036176752     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.53.082901.103945     Document Type: Review

References (100)

1. Are stimulants overprescribed? Treatment of ADHD in four U.S. communities
2. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents
3. The epidemiology of attention-deficit hyperactivity disorders
4. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders
5. Presenting ADHD symptoms and subtypes in clinically referred adults with ADHD
6. Toward defining a neuropsychology of ADHD: Performance of children and adolescents from a large clinically referred sample
7. Validity of DSM-IV ADHD predominantly inattentive and combined types: Relationship to previous DSM diagnoses/subtype differences
8. External validation of oppositional disorder and attention deficit disorder with hyperactivity
9. Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample
10. Age dependent decline of ADHD symptoms revisited: Impact of remission definition and symptom subtype
11. Hyperactive boys almost grown up. I. Psychiatric status
12. Controlled prospective fifteen year follow-up of hyperactives as adults: Non-medical drug and alcohol use and anti-social behaviour
13. The hyperactive child grows up: Predictors of symptoms, delinquency and achievement at follow-up
14. Developmental change in attention-deficit hyperactivity disorder in boys: A four-year longitudinal study
15. Long-term outcome of hyperactive children: A review
16. Review of follow-up and follow-back studies of childhood hyperactivity
17. Long-term outcome in attention-deficit hyperactivity disorder
18. Adult outcome of hyperactive boys: Educational achievement, occupational rank and psychiatric status
19. Predictors of persistence and remission of ADHD into adolescence: Results from a four-year prospective follow-up study
20. Persistence of ADHD into adulthood: It depends on whom you ask
21. DSM-III disorders in preadolescent children: Prevalence in a large sample from the general population
22. Patterns of psychiatric comorbidity in a community sample of children aged 9 through 16 years
23. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders
24. Comorbidity in outcome of attention-deficit hyperactivity disorder
25. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder
26. Depressive comorbidity in children and adolescents: Empirical, theoretical and methodological issues
27. Further distinctions between manic-depressive illness (bipolar disorder) and primary depressive disorder (unipolar depression)
28. Attention deficit hyperactivity disorder and juvenile mania: An overlooked comorbidity?
29. Is comorbidity with ADHD a marker for juvenile onset mania?
30. Attention deficit hyperactivity disorder and comorbid disorders: Issues of overlapping symptoms
31. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders
32. Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence?
33. ADHD is associated with early initiation of cigarette smoking in children and adolescents
34. Psychoactive substance use disorder in adults with attention deficit hyperactivity disorder: Effects of ADHD and psychiatric comorbidity
35. Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD
36. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder
37. Gender differences in ADHD: A meta-analysis and critical review
38. Family study of girls with attention deficit hyperactivity disorder
39. Gender differences in ADHD: A meta-analysis and critical review
40. Comparative effects of methylphenidate on ADD girls and ADD boys
41. Quantitative morphology of the corpus callosum in attention deficit hyperactivity disorder
42. Attention deficit-hyperactivity disorder and asymmetry of the caudate nucleus
43. Cerebral glucose metabolism in adults with hyperactivity of childhood onset
44. The neurobiology of attention-deficit/hyperactivity disorder
45. Corpus callosum morphology in attention-deficit hyperactivity disorder: Morphometric analysis of MRI
46. Quantitative brain magnetic resonance imaging in girls with ADHD
47. Reduced brain metabolism in hyperactive girls
48. Effects of acute stimulant medication on cerebral metabolism in adults with hyperactivity
49. Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment
50. Dopamine transporter density in patients with attention deficit hyperactivity disorder
51. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography
52. Pharmacotherapy of attention deficit disorder across the life cycle
53. Nicotinic systems and cognitive function
54. Release of dopamine and 5-hydroxytryptamine from rat striatal slices following activation of nicotinic cholinergic receptors
55. Toward behavioral genomics
56. Genetics of attention-deficit hyperactivity disorder
57. A twin study of hyperactivity. I. An examination of hyperactivity scores and categories derived from Rutter teacher and parent questionnaires
58. Attention-deficit hyperactivity disorder: A category or a continuum? Genetic analysis of a large-scale twin study
59. Association of attention deficit disorder and the dopamine transporter gene
60. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder
61. Meta-analysis of the association between the 7-repeat allele of the dopamine D4 receptor gene and ADHD
62. Empirically supported psychosocial treatments for attention deficit hyperactivity disorder
63. Cognitive training in ADHD children: Less to it than meets the eye
64. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD
65. Pharmacotherapy of attention-deficit/hyperactivity disorder: A life span perspective
66. Stimulants and antidepressant pharmacokinetics in hyperactive children
67. Pharmacology of amphetamines
68. Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children
69. The stimulants revisited
70. Controlled clinical trial of an extended release form of methylphenidate in children with ADHD
71. The use of psychotropic medication in preschoolers: Indications, safety, and efficacy
72. Effects of methylphenidate in adolescents with attention deficit disorder
73. A double blind, crossover comparison of methylphenidate and placebo in adults with childhood onset attention deficit hyperactivity disorder
74. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systemic, placebo-controlled evaluation
75. Depression of growth in hyperactive children on stimulant drugs
76. Predictors of adult height and weight in boys treated with methylphenidate for childhood behavior problems
77. Growth deficits in ADHD children
78. Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder
79. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: Effects of stimulant and dose
80. Intranasal abuse of prescribed methylphenidate by an alcohol and drug abusing adolescent with ADHD
81. A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder
82. Another sudden death in a child treated with desipramine
83. Bupropion hydrochloride in attention deficit disorder with hyperactivity
84. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults
85. Bupropion SR in adolescents with combined attention-deficit/hyperactivity disorder and depression
86. Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-crossover therapeutic trial
87. Combining methylphenidate and clonidine: A clinically sound medication option
88. Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder
89. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: A systematic chart review of 62 cases
90. Systematic chart review of the pharmacologic treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder